Glutathione in cancer progression and chemoresistance: an update in: Redox Experimental Medicine Volume 2023 Issue 1 (2023) Glutathione Transferase P1: Potential Therapeutic Target in Ovarian Cancer Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti tumor activity in MYC high high grade serous ovarian carcinoma ScienceDirect PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA proficient ovarian cancer ScienceDirect
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
glutathione ovarian cancer PDF) Cellular glutathione level does not predict ovarian cancer cells' resistance after initial or repeated exposure to cisplatin